Testing a new artificial urinary sphincter for men
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new artificial urinary sphincter (a device that helps control urine flow) for men with severe stress incontinence (leakage during activity) that has lasted over a year. If you qualify, the device is implanted to help you stay dry. It is not for everyone, so the study will check your health history carefully.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male aged 18 to 80.
- You must have had stress urinary incontinence (leakage when coughing, sneezing, or straining) for more than 12 months, and it must be severe (confirmed by a pad test).
- You must be willing to have the device and not undergo MRI scans in the future.
- You must be able to operate the device's remote control and attend follow-up visits.
- You must not have certain medical conditions or prior surgeries (e.g., previous artificial sphincter, pelvic radiation, bladder tumor, untreated overactive bladder, or severe urethral narrowing).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows men who have urine leakage from stress (leakage with movement/coughing) after prostate surgery and receive a ProACT device. It looks at long-term outcomes over 5 years and checks safety, including for those who may need device removal or other treatments.
This study follows people who choose surgery using a synthetic under-the-urethra vaginal sling for stress urinary incontinence (urine leakage with coughing or exertion). It aims to track outcomes over time and help confirm the sling is safe and works as intended.
This trial tests a non-surgical, non-drug treatment that uses gentle electrical stimulation on the skin to help strengthen the muscles that control urine leakage. It's for men who still have urinary incontinence at least 6 months after their prostate cancer treatment.
This study tests a new device called an artificial urinary sphincter that is implanted to help control severe stress urinary incontinence (leakage when coughing, sneezing, or exercising) in women. The device aims to provide a long-term solution for those who have not improved with other treatments.
This study tests a new device called UrOActive that helps men with stress urinary incontinence (leaking urine when coughing, sneezing, or moving). It aims to see if the device is safe and works well to control leaks.
This registry study follows men who have ongoing “stress” urine leakage after prostate cancer treatment and choose a sling or an artificial urinary sphincter. It aims to better understand outcomes and quality of life, and your care team uses check-in visits and questionnaires to track progress.
Hear when a new Stress Urinary Incontinence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.